NO20075206L - Medisinske sammensetninger av salter, chelatorer og/eller frie syrer av alfa hydroksyl organiske syrer samt relaterte prosesser og fremgangsmater - Google Patents

Medisinske sammensetninger av salter, chelatorer og/eller frie syrer av alfa hydroksyl organiske syrer samt relaterte prosesser og fremgangsmater

Info

Publication number
NO20075206L
NO20075206L NO20075206A NO20075206A NO20075206L NO 20075206 L NO20075206 L NO 20075206L NO 20075206 A NO20075206 A NO 20075206A NO 20075206 A NO20075206 A NO 20075206A NO 20075206 L NO20075206 L NO 20075206L
Authority
NO
Norway
Prior art keywords
processes
alpha
organic acids
hydroxy organic
acids
Prior art date
Application number
NO20075206A
Other languages
English (en)
Norwegian (no)
Inventor
Ronald W Pero
Original Assignee
Ronald W Pero
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ronald W Pero filed Critical Ronald W Pero
Publication of NO20075206L publication Critical patent/NO20075206L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20075206A 2005-03-16 2007-10-11 Medisinske sammensetninger av salter, chelatorer og/eller frie syrer av alfa hydroksyl organiske syrer samt relaterte prosesser og fremgangsmater NO20075206L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66244605P 2005-03-16 2005-03-16
PCT/US2006/009394 WO2006101922A2 (en) 2005-03-16 2006-03-16 Medicinal compositions of salts, chelates and/or free acids of alpha hydroxyl organic acids and related processes and methods

Publications (1)

Publication Number Publication Date
NO20075206L true NO20075206L (no) 2007-12-17

Family

ID=37024369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075206A NO20075206L (no) 2005-03-16 2007-10-11 Medisinske sammensetninger av salter, chelatorer og/eller frie syrer av alfa hydroksyl organiske syrer samt relaterte prosesser og fremgangsmater

Country Status (10)

Country Link
US (1) US20090275656A1 (ru)
EP (1) EP1858500A4 (ru)
JP (1) JP2008533163A (ru)
AU (1) AU2006227661A1 (ru)
CA (1) CA2609615A1 (ru)
MX (1) MX2007011200A (ru)
NO (1) NO20075206L (ru)
RU (1) RU2007138220A (ru)
WO (1) WO2006101922A2 (ru)
ZA (1) ZA200707757B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009544587A (ja) * 2006-07-11 2009-12-17 リンピート トレーディング ６ （ピーティーワイ） リミテッド トレーディング アズ ジェネティック ヘルス エンタープライゼス トリプトファン及びニコチンアミドのインビボでのレベルの増大方法
DE102007052223A1 (de) * 2007-10-31 2009-05-14 Bionorica Ag Hydrolysate aus Pflanzenextrakten sowie diese enthaltendes antibakterielles Mittel
JP5334508B2 (ja) * 2008-09-10 2013-11-06 Ｔｏｗａ Ｃｏｒｐｏｒａｔｉｏｎ 株式会社 高活性ｐｏａの製法
CN103826649B (zh) 2011-08-19 2016-12-07 比诺里卡公司 生产干燥提取物的方法
CA2875504C (en) 2012-06-11 2022-07-05 Callaghan Innovation Research Limited Feijoa fruit extract
US10098922B1 (en) * 2017-11-30 2018-10-16 Optigenex, Inc. Increasing telomere length in a cell

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
US6238675B1 (en) * 1997-02-27 2001-05-29 Campamed Corp. Method of preparation and composition of a water soluble extract of the plant species Uncaria for enhancing immune, anti-inflammatory and anti-tumor processes of warm blooded animals
US6361805B2 (en) * 1997-02-27 2002-03-26 Ronald W. Pero Method of preparation and composition of a water soluble extract of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals
US6039949A (en) * 1997-02-27 2000-03-21 Campamed, Inc. Method of preparation and composition of a water soluble extract of the plant species uncaria
JPH11140014A (ja) * 1997-11-10 1999-05-25 Mitsui Chem Inc キナ酸の精製方法
EP1339729A2 (en) * 2000-11-28 2003-09-03 The Regents Of The University Of California Anti-inflammatory compounds derived from pseudopterogorgia elisabethae
US6964784B2 (en) * 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs

Also Published As

Publication number Publication date
US20090275656A1 (en) 2009-11-05
EP1858500A4 (en) 2013-01-16
RU2007138220A (ru) 2009-04-27
WO2006101922A3 (en) 2007-09-13
EP1858500A2 (en) 2007-11-28
MX2007011200A (es) 2008-04-02
WO2006101922A2 (en) 2006-09-28
JP2008533163A (ja) 2008-08-21
ZA200707757B (en) 2012-02-29
AU2006227661A1 (en) 2006-09-28
CA2609615A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
NO20075206L (no) Medisinske sammensetninger av salter, chelatorer og/eller frie syrer av alfa hydroksyl organiske syrer samt relaterte prosesser og fremgangsmater
BR112013020620A2 (pt) análogos de ácido 4-hidroxibutírico
AR075423A1 (es) Composicion farmaceutica que comprende un inhibidor de sglt-2, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y sus usos
BR112012009215A2 (pt) "terapia combinada contra o cancer com compostos inibidores de hsp90"
NO20091605L (no) Pyridinonforbindelser
BRPI0514448A (pt) derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
WO2008040548A3 (en) Treatment for non-alcoholic-steatohepatitis
BR112012017073A2 (pt) Método de tratamento de condições neurológicas com glicosídeos cardíacos
MX2007005679A (es) Metodo para tratamiento de desordenes de movimiento.
CO6410306A2 (es) Inhibidor de sglt2 para tratar diabetes mellitus de tipo 1, diabetes mellitus de tipo 2, alteración de la tolerancia a la glucosa e hiperglucemia
BRPI0504145A (pt) composições com um efeito de depósito para o controle de microorganismos
CU23552A1 (es) Composición vacunal
EA201070477A1 (ru) Транс-кломифен для лечения метаболического синдрома
HK1114876A1 (en) Arthrospira-based compositions and uses thereof
BRPI0517846A (pt) azaindolcarboxamidas
BR112013010918A2 (pt) sal de alumínio contendo elevada percentagem de al30
MX2009005413A (es) Formas cristalinas del acido zoledronico.
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
MX2010003603A (es) Metodo para el tratamiento de enfermedades de riñon poliquisticas con derivados de ceramida.
BR112013020586A2 (pt) Uso de células derivadas de tecido do cordão umbilical
BRPI0510370A (pt) derivados de ácido fenoxi-alquil-carboxìlico no tratamento de doenças inflamatórias
BRPI0607156A2 (pt) composto, composição farmacêutica, uso do composto, kit farmacêutico, método para estimular a absorção de glicose por células de músculo e/ou célula de adipócito e método para estimular a secreção pancreática
BR112013028598A2 (pt) método para promover o crescimento de plantas
MX2023001298A (es) Combinaciones para el tratamiento de cancer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application